Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) EBIT: 2011-2024

Historic EBIT for MediWound (MDWD) over the last 14 years, with Dec 2024 value amounting to -$19.4 million.

  • MediWound's EBIT fell 28.42% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.6 million, marking a year-over-year decrease of 37.07%. This contributed to the annual value of -$19.4 million for FY2024, which is 26.88% down from last year.
  • Latest data reveals that MediWound reported EBIT of -$19.4 million as of FY2024, which was down 26.88% from -$15.3 million recorded in FY2023.
  • In the past 5 years, MediWound's EBIT registered a high of -$8.3 million during FY2022, and its lowest value of -$19.4 million during FY2024.
  • For the 3-year period, MediWound's EBIT averaged around -$14.3 million, with its median value being -$15.3 million (2023).
  • Per our database at Business Quant, MediWound's EBIT plummeted by 296.75% in 2020 and then increased by 25.63% in 2022.
  • Over the past 5 years, MediWound's EBIT (Yearly) stood at -$8.8 million in 2020, then decreased by 26.93% to -$11.2 million in 2021, then rose by 25.63% to -$8.3 million in 2022, then crashed by 83.22% to -$15.3 million in 2023, then fell by 26.88% to -$19.4 million in 2024.